We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Still Silent on Alternative Drug Pricing Plan as Election Draws Nearer
Industry Still Silent on Alternative Drug Pricing Plan as Election Draws Nearer
President Trump’s efforts to coax a new strategy from industry to lower drug prices by means of a brandished executive order have been met with silence so far, and the administration is running out of time to show some headway on drug pricing before the Nov. 3 presidential election.